A - Human Necessities – 23 – L
Patent
A - Human Necessities
23
L
A23L 1/305 (2006.01) A23C 9/152 (2006.01) A23C 9/20 (2006.01) A23L 1/30 (2006.01) A61K 31/194 (2006.01) A61K 31/198 (2006.01) A61K 38/01 (2006.01)
Patent
CA 2383100
Disclosed herein are infant dietary supplements containing L-aspartic and/or L- malic acid. The supplements are designed to inhibit .beta.-glucuronidase activity in breast feeding babies, and thereby suppress serum bilirubin levels and the incidence of neonate jaundice. In one form L-aspartic acid or L-malic acid are mixed with human breast milk and fed to the neonate on the same schedule that breast feeding would otherwise normally occur.
Cette invention concerne des compléments alimentaires pour nourrissons qui renferment de l'acide L-aspartique et/ou L-malique. Ces suppléments sont destinés à inhiber l'activité de la .beta.-glucuronidase chez le nourrisson, et par là de supprimer les niveaux sériques de la bilirubine et l'incidence de la jaunisse néonatale. Selon un mode de réalisation, l'acide L-aspartique ou l'acide L-malique est mélangé à du lait maternel et donné au nouveau né aux mêmes intervalles que si ce dernier prenait normalement le sein.
Gourley Glenn R.
Kreamer Bill L.
Borden Ladner Gervais Llp
Wisconsin Alumni Research Foundation
LandOfFree
Aspartic and malic acid inhibition of .beta.-glucuronidase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aspartic and malic acid inhibition of .beta.-glucuronidase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aspartic and malic acid inhibition of .beta.-glucuronidase will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1361062